TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Novavax AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
541,067
|
831,037
|
1,486,017 |
| Financial expenses |
52,993
|
688,978
|
730,503 |
| Earnings before taxes |
268,421
|
197,440
|
490,161 |
| EBITDA |
145,479
|
226,686
|
507,948 |
| Total assets |
2,738,089
|
3,662,856
|
3,545,100 |
| Current assets |
141,668
|
208,191
|
2,494,778 |
| Current liabilities |
135,165
|
1,336,130
|
1,571,319 |
| Equity capital |
2,601,496
|
2,326,726
|
1,973,781 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
173
|
195
|
167 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
95.0%
|
63.5%
|
55.7% |
| Turnover per employee |
3,128
|
4,262
|
8,898 |
| Profit as a percentage of turnover |
49.6%
|
23.8%
|
33.0% |
| Return on assets (ROA) |
11.7%
|
24.2%
|
34.4% |
| Current ratio |
104.8%
|
15.6%
|
158.8% |
| Return on equity (ROE) |
10.3%
|
8.5%
|
24.8% |
| Change turnover |
-304,954
|
-760,423
|
558,179 |
| Change turnover % |
-36%
|
-48%
|
60% |
| Chg. No. of employees |
-22
|
28
|
167 |
| Chg. No. of employees % |
-11%
|
17% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.